Hepatocellular carcinoma in young morbid obese patients with non-alcoholic fatty liver disease

被引:2
|
作者
Tobari, Maki [1 ]
Hashimoto, Etsuko [2 ]
Taniai, Makiko [2 ]
Nishino, Takayoshi [1 ]
Tokushige, Katsutoshi [2 ]
机构
[1] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Internal Med & Gastroenterol, 477-96 Owada Shinden, Yachiyo, Chiba, Japan
[2] Tokyo Womens Med Univ, Inst Gastroenterol, Shinjyuku Ku, 8-1 Kawada Cho, Tokyo, Japan
关键词
Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Hepatocellular carcinoma; Obesity; BODY-MASS INDEX; DIABETES-MELLITUS; EPIDEMIOLOGIC EVIDENCE; RISK; CANCER; ASSOCIATION; HCC; METAANALYSIS; MANAGEMENT; OVERWEIGHT;
D O I
10.1007/s12328-020-01215-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We report the two youngest cases of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) among our 119 NAFLD-HCC patients. A 36-year-old man was referred to our hospital due to a 5 cm in diameter liver tumor with elevation of alpha-fetoprotein and des-gamma-carboxy prothrombin found at his annual health check. He had no symptoms other than 20 kg weight loss. He has been morbidly obese since he was a child. At the time of the diagnosis of NAFLD-HCC, blood chemistry showed FIB4-index 0.52, alpha-fetoprotein 11.1 ng/mL and des-gamma-carboxy prothrombin 361 mAU/mL. He underwent curative operation. The non-cancerous lesion showed steatohepatitis with mild fibrosis. A 41-year-old man was diagnosed as having a huge liver tumor (15 cm in diameter) during medical examination for 10 kg weight loss. He had no clinical symptoms except weight loss. He has been morbidly obese since childhood. NAFLD was diagnosed at age 20. At the time of the HCC diagnosis, blood chemistry showed FIB4-index 1.42, alpha-fetoprotein 1974 ng/mL, and des-gamma-carboxy prothrombin 82,602 mAU/mL. He underwent curative operation. We have to be aware that HCC can develop in young NAFLD patients without advanced fibrosis. Concerning tumor markers, elevation of des-gamma-carboxy prothrombin was more sensitive than alpha-fetoprotein.
引用
收藏
页码:1289 / 1296
页数:8
相关论文
共 50 条
  • [1] Hepatocellular carcinoma in young morbid obese patients with non-alcoholic fatty liver disease
    Maki Tobari
    Etsuko Hashimoto
    Makiko Taniai
    Takayoshi Nishino
    Katsutoshi Tokushige
    Clinical Journal of Gastroenterology, 2020, 13 : 1289 - 1296
  • [2] Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
    Carrie R Wong
    Mindie H Nguyen
    Joseph K Lim
    World Journal of Gastroenterology, 2016, 22 (37) : 8294 - 8303
  • [3] Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
    Wong, Carrie R.
    Nguyen, Mindie H.
    Lim, Joseph K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (37) : 8294 - 8303
  • [4] Hepatocellular carcinoma and non-alcoholic fatty liver disease
    Golabi, Pegah
    Rhea, Logan
    Henry, Linda
    Younossi, Zobair M.
    HEPATOLOGY INTERNATIONAL, 2019, 13 (06) : 688 - 694
  • [5] Hepatocellular carcinoma and non-alcoholic fatty liver disease
    Pegah Golabi
    Logan Rhea
    Linda Henry
    Zobair M. Younossi
    Hepatology International, 2019, 13 : 688 - 694
  • [6] Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
    El Dahan, Karim Seif
    Daher, Darine
    Singal, Amit G.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 : S207 - S219
  • [7] Risk of Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease
    Kim, Dong Yun
    Park, Jun Yong
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2021, 78 (01): : 69 - 71
  • [8] A review on fatty liver disease or non-alcoholic fatty liver disease and hepatocellular carcinoma
    Toman, Daniel
    Vavra, Petr
    Jelinek, Petr
    Ostruszka, Petr
    Ihnat, Peter
    Foltys, Ales
    Roman, Jan
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2021, 16 (10): : 156 - 162
  • [9] Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma
    Younossi, Zobair M.
    Henry, Linda
    JHEP REPORTS, 2021, 3 (04)
  • [10] Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
    Hydes, Theresa J.
    Cuthbertson, Daniel J.
    Palmer, Daniel H.
    Elshaarawy, Omar
    Johnson, Philip J.
    Fernando, Rashika
    Cross, Timothy J.
    HEPATOMA RESEARCH, 2023, 9